Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Applikon Biotechnology
Applikon Biotechnology
X
LinkedIn
Trending Articles
AbbVie and Gedeon Richter join forces to advance neuropsychiatric target R&D
The companies will aim to discover and progress targets for neuropsychiatric disorders
Containment in a high potent manufacturing facility
Throughout the pharmaceutical industry, there is a lack of consistency regarding the assignment of Occupational Exposure Limits (OELs) to specific bands
Rousselot
Rousselot is the global leader* of collagen-based solutions for the food, health and nutrition, biomedical and pharmaceutical sectors. Working in partnership with our global...
Tabletability, compactability and compressibility: What’s the difference?
To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
Causes and solutions for dark spots in tablet manufacturing
Natoli Engineering examines the causes and solutions for dark spots that can halt production
Upcoming event
Lab Innovations
30-31 October 2024 | Exhibition | Birmingham, UK
See all
Related Content
You need to be a subscriber to read this article.
Click here
to find out more.
Pharmaceutical
Diversity aids a biotech boom
The biotech sector is boosted by invention and shows no sign of slowing. Biopharmaceutical pipelines are broadening and production techniques improving. Susan Birks reports
Manufacturing
Microbioreactor rapidly handles microbial strains, clone libraries and cells
Micro-Matrix offers 24 independent bioreactors in microtitre plate footprint
Manufacturing
Applikon Biotechnology officially opens a new production facility in China
Event will be combined with a scientific seminar on bioreactor technology innovations
Manufacturing
King Willem-Alexander of the Netherlands to open new headquarters of Applikon Biotechnology
New facility includes offices, R&D laboratories and a state-of-the-art warehouse
Manufacturing
Applikon Biotechnology starts construction of new facility in Delft
The building will accommodate 100 people and be completed next summer
Subscribe now